Page 23 - 中国全科医学2022-15
P. 23
·1812· http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn
STW 5 in functional dyspepsia and IBS:the origin of multi- Gastroenterology,2016,150(6):1257-1261. DOI:10.1053/j.
target[J]. Dig Dis,2017,35(Suppl 1):18-24. DOI: gastro.2016.03.035.
10.1159/000485456. [51]GWEE K A,GONLACHANVIT S,GHOSHAL U C,et al.
[38]MADISCH A,HOLTMANN G,PLEIN K,et al. Treatment of Second Asian consensus on irritable bowel syndrome[J].
irritable bowel syndrome with herbal preparations:results of a J Neurogastroenterol Motil,2019,25(3):343-362. DOI:
double-blind,randomized,placebo-controlled,multi-centre 10.5056/jnm19041.
trial[J]. Aliment Pharmacol Ther,2004,19(3):271-279. [52]KOLOSKI N A,JONES M,KALANTAR J,et al. The brain—gut
DOI:10.1111/j.1365-2036.2004.01859.x. pathway in functional gastrointestinal disorders is bidirectional:a
[39]张伟,孙建华,裴丽霞,等 . 中医药治疗肠易激综合征的系统 12-year prospective population-based study[J]. Gut,2012,61
评价 /Meta 分析的再评价[J]. 世界华人消化杂志,2014,22 (9):1284-1290. DOI:10.1136/gutjnl-2011-300474.
(12):1747-1755. [53]中华医学会消化病学分会胃肠功能性疾病协作组,中华医学
[40]ACHAMRAH N,DÉCHELOTTE P,COËFFIER M. Glutamine 会消化病学分会胃肠动力学组 . 2020 年中国肠易激综合征专
and the regulation of intestinal permeability:from bench to 家共识意见[J]. 中华消化杂志,2020,40(12):803-818.
bedside[J]. Curr Opin Clin Nutr Metab Care,2017,20(1): DOI:10.3760/cma.j.cn311367-20201116-00660.
86-91. DOI:10.1097/MCO.0000000000000339. Study Group of Functional Gastrointestinal Disorders,Study Group
[41]陈晓敏,罗云,江敏,等 . 结肠黏膜褪黑素受体表达与肠易激 of Gastrointestinal Motility,Chinese Society of Gastroenterology,
综合征症状相关性研究[J]. 胃肠病学和肝病学杂志,2015, Chinese Medical Association. Chinese expert consensus of irritable
24(8):943-945. DOI:10.3969/j.issn.1006-5709.2015.08.013. bowel syndrome in 2020[J]. Chinese Journal of Digestion,
[42]陈晓敏,江敏,罗云,等 . 褪黑素治疗伴有睡眠障碍的肠易激 2020,40(12):803-818. DOI:10.3760/cma.j.cn311367-
综合征的临床研究[J]. 深圳中西医结合杂志,2015,25(2): 20201116-00660.
1-3. DOI:10.16458/j.cnki.1007-0893.2015.02.001. [54]李彦楠,杨丽旋,赵钟辉,等 . 《2020 年中国肠易激综合征专
[43]SIAH K T,WONG R K,HO K Y. Melatonin for the treatment of 家共识意见》解读[J]. 中国临床医生杂志,2021,49(10):
irritable bowel syndrome[J]. World J Gastroenterol,2014,20 1151-1155. DOI:10.3969/j.issn.2095-8552.2021.10.006.
(10):2492-2498. DOI:10.3748/wjg.v20.i10.2492. [55]KOLOSKI N,HOLTMANN G,TALLEY N J. Is there a causal
[44]BARBALHO S M,GOULART R A,ARAÚJO A C,et al. Irritable link between psychological disorders and functional gastrointestinal
bowel syndrome:a review of the general aspects and the potential disorders? [J]. Expert Rev Gastroenterol Hepatol,2020,14(11):
role of vitamin D[J]. Expert Rev Gastroenterol Hepatol,2019, 1047-1059. DOI:10.1080/17474124.2020.1801414.
13(4):345-359. DOI:10.1080/17474124.2019.1570137. [56]LACKNER J M. Skills over pills? A clinical gastroenterologist's
[45]ABBASNEZHAD A,AMANI R,HASANVAND A,et al. primer in cognitive behavioral therapy for irritable bowel
Association of serum vitamin D concentration with clinical symptoms syndrome[J]. Expert Rev Gastroenterol Hepatol,2020,14(7):
and quality of life in patients with irritable bowel syndrome[J]. 601-618. DOI:10.1080/17474124.2020.1780118.
J Am Coll Nutr,2019,38(4):327- 333. DOI: [57]ZIJDENBOS I L,DE WIT N J,VAN DER HEIJDEN G J,et al.
10.1080/07315724.2018.1510349. Psychological treatments for the management of irritable bowel
[46]GLABSKA D,KOLOTA A,LACHOWICZ K,et al. Vitamin D syndrome[J]. Cochrane Database Syst Rev,2009(1):
supplementation and mental health in inflammatory bowel diseases CD006442. DOI:10.1002/14651858.CD006442.pub2.
and irritable bowel syndrome patients:a systematic review[J]. [58]EVERITT H A,LANDAU S,O'REILLY G,et al. Assessing
Nutrients,2021,13(10):3662. DOI:10.3390/nu13103662. telephone-delivered cognitive-behavioural therapy (CBT) and
[47]JALILI M,VAHEDI H,POUSTCHI H,et al. Effects of vitamin web-delivered CBT versus treatment as usual in irritable bowel
D supplementation in patients with irritable bowel syndrome: syndrome (ACTIB):a multicentre randomised trial[J]. Gut,
a randomized,double-blind,placebo-controlled clinical 2019,68(9):1613-1623. DOI:10.1136/gutjnl-2018-317805.
trial[J]. Int J Prev Med,2019,10:16. DOI:10.4103/ijpvm. [59]EVERITT H,LANDAU S,LITTLE P,et al. Therapist telephone-
IJPVM_512_17. delivered CBT and web-based CBT compared with treatment as
[48]KHALIGHI SIKAROUDI M,MOKHTARE M,JANANI L,et al. usual in refractory irritable bowel syndrome:the ACTIB three-arm
Vitamin D3 supplementation in diarrhea-predominant irritable bowel RCT[J]. Health Technol Assess,2019,23(17):1-154.
syndrome patients:the effects on symptoms improvement,serum DOI:10.3310/hta23170.
corticotropin-releasing hormone,and interleukin-6 - a randomized [60]EVERITT H A,LANDAU S,O'REILLY G,et al. Cognitive
clinical trial[J]. Complement Med Res,2020,27(5):302- behavioural therapy for irritable bowel syndrome:24-month
309. DOI:10.1159/000506149. follow-up of participants in the ACTIB randomised trial[J].
[49]PLUDOWSKI P,HOLICK M F,GRANT W B,et al. Vitamin D Lancet Gastroenterol Hepatol,2019,4(11):863-872. DOI:
supplementation guidelines[J]. J Steroid Biochem Mol Biol, 10.1016/S2468-1253(19)30243-2.
2018,175:125-135. DOI:10.1016/j.jsbmb.2017.01.021. [61]WEBB A N,KUKURUZOVIC R H,CATTO-SMITH A G,et al.
[50]DROSSMAN D A,HASLER W L. Rome Ⅳ -functional Hypnotherapy for treatment of irritable bowel syndrome[J].
GI disorders:disorders of gut-brain interaction[J]. Cochrane Database Syst Rev,2007(4):CD005110. DOI: